BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1959888)

  • 1. Autoantibody against dihydrolipoamide dehydrogenase, the E3 subunit of the 2-oxoacid dehydrogenase complexes: significance for primary biliary cirrhosis.
    Maeda T; Loveland BE; Rowley MJ; Mackay IR
    Hepatology; 1991 Dec; 14(6):994-9. PubMed ID: 1959888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis.
    Van de Water J; Cooper A; Surh CD; Coppel R; Danner D; Ansari A; Dickson R; Gershwin ME
    N Engl J Med; 1989 May; 320(21):1377-80. PubMed ID: 2716784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes.
    Fussey SP; Lindsay JG; Fuller C; Perham RN; Dale S; James OF; Bassendine MF; Yeaman SJ
    Hepatology; 1991 Mar; 13(3):467-74. PubMed ID: 1999318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex.
    Fregeau DR; Davis PA; Danner DJ; Ansari A; Coppel RL; Dickson ER; Gershwin ME
    J Immunol; 1989 Jun; 142(11):3815-20. PubMed ID: 2715637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
    Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
    Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis.
    Bassendine MF; Jones DE; Yeaman SJ
    Semin Liver Dis; 1997 Feb; 17(1):49-60. PubMed ID: 9089910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.
    Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME
    Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies of sera from patients with primary biliary cirrhosis recognize the alpha subunit of the decarboxylase component of human branched-chain 2-oxo acid dehydrogenase complex.
    Mori T; Ono K; Hakozaki M; Kasukawa R; Kochi H
    J Hepatol; 2001 Jun; 34(6):799-804. PubMed ID: 11451161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry.
    Teoh KL; Mackay IR; Rowley MJ; Fussey SP
    Hepatology; 1994 Apr; 19(4):1029-33. PubMed ID: 8138243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases.
    Fujikura S; Davis PA; Prindiville T; Leung P; Fox RI; Gershwin ME
    J Rheumatol; 1990 Nov; 17(11):1453-7. PubMed ID: 1703233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.
    Van de Water J; Ansari AA; Surh CD; Coppel R; Roche T; Bonkovsky H; Kaplan M; Gershwin ME
    J Immunol; 1991 Jan; 146(1):89-94. PubMed ID: 1984455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The association between autoantibodies to enzyme and diseases--with special reference to antibodies to pyruvate dehydrogenase complex (PDH)].
    Moteki S; Amaki S; Nakano E
    Rinsho Byori; 1998 Apr; 46(4):317-23. PubMed ID: 9594621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
    Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
    Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis.
    Omagari K; Rowley MJ; Jois JA; Feeney SJ; Komatsu K; Maeda T; Onishi S; Yamazaki K; Suzuki K; Galperin C; Mackay IR
    J Gastroenterol; 1996 Feb; 31(1):61-8. PubMed ID: 8808430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of alpha-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosis.
    Fregeau DR; Prindiville T; Coppel RL; Kaplan M; Dickson ER; Gershwin ME
    Hepatology; 1990 Jun; 11(6):975-81. PubMed ID: 2365294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis.
    Harada K; Sudo Y; Kono N; Ozaki S; Tsuneyama K; Gershwin ME; Nakanuma Y
    Hepatology; 1999 Jul; 30(1):36-45. PubMed ID: 10385636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis.
    Palmer JM; Jones DE; Quinn J; McHugh A; Yeaman SJ
    Hepatology; 1999 Jul; 30(1):21-6. PubMed ID: 10385634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of mitochondrial autoreactivity in primary biliary cirrhosis.
    Mackay IR; Gershwin ME
    Immunol Today; 1989 Sep; 10(9):315-8. PubMed ID: 2480138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function.
    Van de Water J; Fregeau D; Davis P; Ansari A; Danner D; Leung P; Coppel R; Gershwin ME
    J Immunol; 1988 Oct; 141(7):2321-4. PubMed ID: 3049806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cellular immune responses to dihydrolipoamide dehydrogenase (E3): lack of specificity for primary biliary cirrhosis.
    Tanaka H; Maeda T; Onishi S; Yamamoto Y
    Liver; 1995 Jun; 15(3):121-5. PubMed ID: 7674838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.